ReviewPLoS medicine2020
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.
Abstract readReview
In one paragraph
Review in PLoS medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Navigating the human gene editing scene and proposing a new governance framework in Africa: from knowledge to policy to action.Frontiers in genome editing · 2026Article
- Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative.Pharmaceutical medicine · 2025Article
- Performance analysis of EAC joint GMP inspections (2016-2022): a pathway to strengthening regulatory systems and building capacity in Africa's less resourced authorities.Frontiers in medicine · 2025Article
- Evaluation of the implementation and the associated operating costs of a medicine regulatory harmonisation model in Africa: the case of ZaZiBoNa, a SADC work-sharing initiative.Journal of pharmaceutical policy and practice · 2025Article
- Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries.Journal of pharmaceutical policy and practice · 2025Article
- The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.Health policy and planning · 2024Article
- Strengthening regulation for medical products in Tanzania: An assessment of regulatory capacity development, 1978-2020.PLOS global public health · 2024Article
- Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.Pharmaceutical medicine · 2023Article
- Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.Journal of pharmaceutical policy and practice · 2023Article
- What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.Frontiers in medicine · 2023Review
- The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.Frontiers in medicine · 2023Article
- The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.Journal of pharmaceutical policy and practice · 2022Article
- Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example?BMJ paediatrics open · 2022Article
- Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.Pharmaceutical medicine · 2022Article
- Needs-driven talent and competency development for the next generation of regulatory scientists in Africa.British journal of clinical pharmacology · 2022Review
- Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.Frontiers in pharmacology · 2022Article
- Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.Frontiers in pharmacology · 2022Article
- Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.Frontiers in medicine · 2022Article
- The Evolving Landscape of Medical Device Regulation in East, Central, and Southern Africa.Global health, science and practice · 2021Review
- Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.BMC public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Jane H MashingiaEast African Community Secretariat, Arusha, Tanzania.ORCID 0000-0003-0812-2021
Vincent AhonkhaiGwynedd Consultancy, LLC, Philadelphia, Pennsylvania, United States of America.
Noel AineplanNational Drug Authority, Kampala, Uganda.
Aggrey AmbaliAfrican Union Development Agency-New Partnership for Africa's Development, Midrand, South Africa.
Apollo AngoleNational Drug Authority, Kampala, Uganda.ORCID 0000-0001-7136-706X
Mawien ArikDrug and Food Control Authority, Juba, South Sudan.
Samvel AzatyanWorld Health Organization, Geneva, Switzerland.
Peter BaakDrug and Food Control Authority, Juba, South Sudan.
Emmanuel BamenyekanyeDirectorate of Pharmacy, Medicines, and Laboratories, Bujumbura, Burundi.
Aimable BizozaRwanda Food & Drugs Authority, Kigali, Rwanda.
Chimwemwe ChamdimbaAfrican Union Development Agency-New Partnership for Africa's Development, Midrand, South Africa.ORCID 0000-0002-9016-4193
Petra DoerrPetra Doerr Consulting Ltd., Herznach, Switzerland.ORCID 0000-0003-4252-7719
Adam FimboTanzania Medicines and Medical Devices Authority, Dar Es Salaam, Tanzania.ORCID 0000-0002-9356-2218
Alex GisagaraRwanda Food & Drugs Authority, Kigali, Rwanda.
Hidaya HamadZanzibar Food & Drug Agency, Zanzibar City, Zanzibar.
Rachelle HarrisHarris Access Consulting Ltd, London, United Kingdom.ORCID 0000-0002-8737-0949
Dan HartmanBill & Melinda Gates Foundation, Seattle, Washington, United States of America.ORCID 0000-0003-0560-8923
Joseph KabatendeRwanda Food & Drugs Authority, Kigali, Rwanda.ORCID 0000-0002-3718-3213
Charles KarangwaRwanda Food & Drugs Authority, Kigali, Rwanda.ORCID 0000-0002-8233-2126
Agnes Sitta KijoTanzania Medicines and Medical Devices Authority, Dar Es Salaam, Tanzania.ORCID 0000-0002-4832-2215
Murray LumpkinBill & Melinda Gates Foundation, Seattle, Washington, United States of America.ORCID 0000-0002-8708-7617
Shani MabokoTanzania Medicines and Medical Devices Authority, Dar Es Salaam, Tanzania.
David MatleTanzania Medicines and Medical Devices Authority, Dar Es Salaam, Tanzania.ORCID 0000-0001-7983-3061
Apollo MuhairweWorld Bank, Washington DC, United States of America.
John Patrick MwesigyeEast African Community Secretariat, Arusha, Tanzania.
Bonaventure NyabendaDirectorate of Pharmacy, Medicines, and Laboratories, Bujumbura, Burundi.
Alexander SchulzeSwiss Agency for Development and Cooperation, Bern, Switzerland.
Andreas SeiterWorld Bank, Washington DC, United States of America.
Gordon SematikoNational Drug Authority, Kampala, Uganda.
Margareth SigondaAfrican Union Development Agency-New Partnership for Africa's Development, Midrand, South Africa.ORCID 0000-0002-0395-063X
Hiiti SilloWorld Health Organization, Geneva, Switzerland.
Burhani SimaiZanzibar Food & Drug Agency, Zanzibar City, Zanzibar.ORCID 0000-0003-3286-7912
Fred SiyoiPharmacy & Poisons Board, Nairobi, Kenya.ORCID 0000-0003-1113-1789
Stanley SonoiyaEast African Community Secretariat, Arusha, Tanzania.ORCID 0000-0003-3476-6226
Paul TanuiAfrican Union Development Agency-New Partnership for Africa's Development, Midrand, South Africa.
Mike WardWorld Health Organization, Geneva, Switzerland.
Felistas YanoPharmacy & Poisons Board, Nairobi, Kenya.ORCID 0000-0003-4440-8481
David MukangaBill & Melinda Gates Foundation, Seattle, Washington, United States of America.ORCID 0000-0001-5554-7466
Funding
World Health Organization 001
Abstract
Jane H. Mashingia and colleagues reveal the progress made to date for the East African Community Medicines Regulatory Harmonization initiative.
Indexed as
Drug ApprovalAfrica, EasternCommunity MedicineDrug and Narcotic ControlHealth Services AccessibilityHumansTime Factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.